SCHEMBL24087902

SCHEMBL24087902

N#Cc1c(-c2cccs2)nc(SCc2noc(=O)[nH]2)[nH]c1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 8/20 0.70
▸ MEN1 O00255 6/20 0.66
▸ KMT2A Q03164 6/20 0.66
▸ PRNP P04156 5/20 0.66
▸ RXFP1 Q9HBX9 5/20 0.66
▸ NPSR1 Q6W5P4 4/20 0.66
▸ POLB P06746 4/20 0.66
▸ USP2 O75604 1/20 0.66
▸ PKM P14618 1/20 0.66
▸ BLM P54132 1/20 0.66
▸ SAE1 Q9UBE0 1/20 0.66
▸ UBA2 Q9UBT2 1/20 0.66
▸ L3MBTL1 Q9Y468 1/20 0.66
▸ MAPT P10636 2/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ CYP2C19 P33261 2/20 0.61
▸ HPGD P15428 2/20 0.61
▸ PSMD14 O00487 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087944 0.83 ACMSD (0.51) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL17548497 0.83 ACMSD (1.00) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL23852241 0.82 MEN1 (0.69) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL24087934 0.82 PRNP (0.63) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL26847396 0.82 PRNP (0.63) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL23892711 0.81 PRNP (0.76) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL17548438 0.79 ACMSD (0.78) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL31053406 0.79 ACMSD (0.78) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL23850223 0.79 ACMSD (0.78) ACMSDMEN1KMT2APRNPRXFP1
SCHEMBL26847258 0.79 MEN1 (0.73) ACMSDMEN1KMT2APRNPRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MEN1 2572/4885KMT2A 1353/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MEN1 2572/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback